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Introduction
Hepatic stellate cells (HSC), liver-specific pericytes, play a
pivotal role in hepatic fibrogenesis. Galectin forms a
group of animal lectins characterized by their specificity
for beta-galactosides. At present, more than 10 galectins
have been identified in mammals [1]. Galectin-1 forms a
homodimer of 14 kDa subunits, and galectin-3 is a mon-
omer having molecular weights of approximately 32 kDa.
Galectin-1 and galectin-3 are localized not only in intrac-
ellular space such as the cytoplasm or the nucleus but also
in extracellular space such as the cell surface or the extra-
cellular matrix. Although the biological functions of galec-
tin-1 and galectin-3 remain speculative in individual cells,
tissues, or diseases, there is evidence that they play a role
in cellular proliferation, differentiation, adhesion, neo-
plastic transformation, apoptosis, neoplastic and extracel-
lular matrix interaction [2-4]. These functions are thought
to act by cross-linking beta-galactoside containing glyco-
conjugates, resulting in modulation of cell signaling [5,6].
Here, we detail the expression pattern of galectin-1 and
galectin-3 in activated HSC and in fibrotic liver tissues. We
further show that both galectins are possible mitogens for
HSC activating MAP kinase pathways presumably by
cross-linking extracellular beta-galactoside.
Methods
Sinusoidal cells and hepatocytes were isolated from rat
liver as described previously and cultured in DMEM con-
taining 10% FCS. Expression of galectin-1 and galectin-3
in these cells and fibrotic livers was evaluated in protein
and mRNA level. Effect of recombinant galectin-1 and
galectin-3 on DNA synthesis of HSC and hepatocytes was
measured by [3H]thymidine incorporation. Activation of
MEK1/2-ERK1/2 and Akt signal pathways was analyzed by
western blot using phospho-specific antibodies. HSC
migration was evaluated by using a cell culture insert. Col-
lagen alpha 2(I) gene expression in stimulated HSC was
assessed.
Results
In hepatic constituent cells isolated from intact liver, only
Kupffer cells exhibited the expression of galectin-3.
Expression of mRNAs and proteins for galectin-1 and
galectin-3 increased time-dependently in HSC during the
primary culture. In TAA-induced fibrotic livers, galectin-1
was expressed in HSC and galectin-3 in HSC and Kupffer
cells. Both galectin-1 and galectin-3 dose-dependently
stimulated DNA synthesis of HSC, but not hepatocytes.
Galectin-1 was found to be a stronger mitogen for HSC
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than galectin-3. Among ERK1/2, p38 MAPK, SAPK/JNK
and Akt, both galectin-1 and galectin-3 induced phospho-
rylation of ERK1/2 at 120 min after addition. Phosphor-
ylation of MEK1/2, upstream signal of ERK1/2, also
happened. Thiodigalactoside, a beta-galactoside-binding
inhibitor, significantly suppressed the galectin-dependent
both ERK1/2 activation and DNA synthesis. These galec-
tin-dependent DNA synthesis and ERK1/2 phosphoryla-
tion were hampered dose-dependently by PD98059 and
U0126, but neither by SB203580 nor LY294002.
Although galectin-1-stimulated ERK1/2 phospholyration
was affected neither by GF109203X, a PKC inhibitor, nor
H-89, a PKA inhibitor, galectin-3-stimulated ERK1/2
phospholyration was attenuated dose-dependently by
these agents. Galectin-1, but not galectin-3, significantly
promoted HSC migration. Neither galectin-1 nor galectin-
3 affected collagen alpha 2(I) mRNA expression in acti-
vated HSC.
Discussion
Our present study revealed that expression of galectin-1
and galectin-3 was induced in activated HSC and fibrotic
livers, and that galectin-1 was found to be more potent
mitogen for HSC than galectin-3. There have been little
reports on the intracellular signal pathways through
which galectins stimulate cell proliferation. We clarified
that HSC proliferation in response to galectin-1 and galec-
tin-3 could be mediated by a MEK1/2-ERK1/2 pathway.
However, PKC and PKA were involved in galectin-3-, but
not galectin-1-, dependent activation of ERK1/2 in HSC.
These results indicated that signal stream toward ERK1/2
stimulation, thereby DNA synthesis of HSC, could be dif-
ferently regulated between galectin-1 and galectin-3. We
speculate that counter receptor of galectin-1 in HSC sur-
face may be different from that of galectin-3, or that the
conformations of cell surface glycoproteins are differently
modified by either galectin-1 or galectin-3.
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